![Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?](https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg)
Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
ZacksPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.